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Dystonia is defined as a syndrome of sustainedmuscle
contractions frequently causing twisting or repetitive
movements or abnormal postures(1). The onset of its
focal form such as cervical dystonia is often preceded
by psychological stress. Although dystonia has been
regarded as a basal ganglia disorder, its precise pa-
thology and molecular pathogenesis have not been
clarified(2).
X-linked recessive dystonia parkinsonism (XDP) is
an adult onset movement disorder characterized by
severe and progressive dystonia with a high fre-
quency of generalization (Fig.1a)(3). Although the
striatal lesion has been the most striking pathology in
this disease, the functional anatomy of the basal gan-
glia circuit in XDP has been a mystery. The mam-
malian striatum can be divided into two complementary
and functionally distinct compartments, the matrix
and the striosomes that are arranged in a mosaic
pattern. Matrix compartment forms the matrix-based
pathways (i.e., the direct and indirect pathways)
that act as push-pull system to increase or decrease
movement(4). Striosomes form the striosomal pathway
that is thought to exert critical control over movement
by modulating the nigral dopaminergic functions
(Fig.1b). We obtained anatomo-pathological evi-
dence that in the XDP neostriatum, the matrix
compartment is relatively spared in a unique fashion
while the striosomes are severely depleted(5). In
view of the three-pathway basal ganglia model(6),
we postulate that the differential involvement of
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neostriatal compartments may underlie the mani-
festation of dystonia in patients with XDP.
XDP, first described in 1976 by Lee and colleagues
as endemic in Panay, Philippines, is predominantly
male movement disorder whose dystonia dominates
the first 10 to 15 years of the illness and is associated or
replaced with parkinsonism in the later years of life(3).
To investigate its striatal pathology, we carried out
postmortem analysis on multiple brain sections from
male Filipino XDP patients who manifested dystonia.
We have reported that the pathology of the XDP stria-
tum is consistent with respect to the neostriatum
(i.e. the caudate nucleus and putamen), but not the
nucleus accumbens(3). Our current findings corroborate
those reported earlier that the neostriatal lesion,
characterized by neuronal loss and astrogliosis, was
not diffusely but rather compartmentally distributed
in a multifocal or mosaic fashion : the mosaic ap-
pearance resulted from islands (patches) of almost
normal striatum sharply demarcated by gliotic area
containing only a few neurons.
To assess the involvement of striatal projection
neurons in XDP, we performed an immunohisto-
chemical study using an antibody to calcineurin (CaN).
CaN can be a neurochemical marker for striatal me-
dium spiny neurons of both the matrix and strioso-
mal compartments and for their axonal projections
in the human basal ganglia. The medium spiny
neurons account for up to 90% of the striatal
neuron population. We found that macroscopi-
cally, there exist two distinct compartments in the
XDP neostriatum, i.e., CaN-positive (CaN+) patches
and inter-patch area devoid of CaN immunoreac-
tivity.
To further elucidate whether the CaN+ patches
found in XDP originated from the striatal matrix or
striosomes, we used immunostaining with antibody to
calbindin, an excellent marker for labeling the striatal
matrix compartment. Double-immunofluorescence
staining disclosed that CaN+ neurons represented
a population that co-localized with calbindin. These
findings indicated that in the XDP neostriatum, the
matrix compartment was relatively spared in amosaic
pattern. However, the striosome compartment was
markedly depleted because of severe neuronal loss
in the inter-patch area.
Normally, efferent projections from the striosomes
and matrix compartment differentially innervate the
substantia nigra : striosomal cells provide inputs to
the location of dopaminergic cells in the substantia
nigra pars compacta (SNc) and islands of dopaminergic
cells in the SNr, while matrix cells provide inputs to
the location of non-dopaminergic (GABAergic) neu-
rons in the SNr.
Our hypothesis on the differential temporal evo-
lution of striosome and matrix involvement in XDP
Fig. 1 a. Dystonic symptomas in DYT3． b. 3-compartment model of basal ganglia.
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is shown in Fig.2a. We postulate that, as was sug-
gested in Huntington’s disease (HD), neuronal loss
may first occur predominantly in the striosomes at
the early stage of disease progression. This may, in
the late stage, result in the characteristic mosaic
appearance presented by islands (patches) of re-
maining matrix cells. Based on the three-pathway
model of the basal ganglia function, we postulate that
at the earlier stage, when dystonia predominantly
manifests, severe loss of striosomal GABAergic pro-
jection neurons that form the striosomal pathway
leads to disinhibition of the nigral dopaminergic neu-
rons and thereby to increased activity of striatal
dopamine function. This then results in the hy-
perkinetic disorder dystonia. At the later stage when
dystonia is less severe and is replaced by parkin-
sonism, the greater involvement of the matrix com-
partment leads to a severe and critical reduction of
matrix-based projections and thus to the development
of so called “extra-nigral form” of parkinsonism
(Fig. 2b).
Among the basal ganglia disorders, XDP shares
common features withHD, another adult onset genetic
disorder;their progression of neurological signs and
striatal pathology that includes the preferential loss
of medium spiny projection neurons. In fact, we found
the causative gene for XDP as TAF1(TATA-binding
protein associated factor 1), which plays a critical
role in gene expression. Similarly, in HD, polyglu-
tamine accumulated in striatal neurons has been
postulated to interfere with DNA transcription(7).
Despite hypotheses to explain the occurrence of hy-
perkinetic symptoms (e.g. chorea) in HD, this in-
triguing issue continues to be debated. Until now, the
focus in the functional anatomy of basal ganglia dis-
orders has been directed at the direct and indirect
pathways to explain the genesis of the disease-
associated hyperkinetic or hypokinetic motor symp-
toms. Based on the present data, we suggest that
the dystonia in XDP may result from an activity
imbalance between the striosomal and matrix-based
pathways, and that XDP, particularly at the earlier
stage, can be a human disease model to study the
implication of reduced striosomal pathway activity
in the genesis of dystonia(8).
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